# Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

> **NCT06064539** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 30 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Tolebrutinib
- **DRUG:** gemfibrozil
- **DRUG:** rifampicin

## Key facts

- **NCT ID:** NCT06064539
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-18
- **Primary completion:** 2020-07-08
- **Final completion:** 2020-07-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06064539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06064539, "Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT06064539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*